Dual RXR agonists and RAR antagonists based on the stilbene retinoid scaffold

ACS Medicinal Chemistry Letters

Volumn 5, Issue 5, 2014, Pages 533-537

  Martínez, Claudio ^a   Lieb, Michele ^b   Álvarez, Susana ^a   Rodríguez Barrios, Fátima ^a   Álvarez, Rosana ^a   Khanwalkar, Harshal ^b   Gronemeyer, Hinrich ^b   De Lera, Angel R ^a  

^a UNIVERSITY OF VIGO   (Spain)

^b INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

agonists; antagonists; arotinoids; molecular modeling; Retinoid receptor subtypes; transactivation

Indexed keywords

ALITRETINOIN; AROTINOID; BENZYLPHOSPHONATE; LIGAND; NAPHTHALDEHYDE; NAPHTHALENE DERIVATIVE; PHOSPHONIC ACID DERIVATIVE; RETINOIC ACID; RETINOIC ACID DERIVATIVE; RETINOIC ACID RECEPTOR AGONIST; RETINOID X RECEPTOR AGONIST; STILBENE; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CELL LINE; DRUG DESIGN; DRUG RECEPTOR BINDING; ELASTICITY; HORNER WADSWORTH EMMONS REACTION; HUMAN; LIGAND BINDING; MOLECULAR DYNAMICS; MOLECULAR MODEL; PRIORITY JOURNAL; TRANSACTIVATION ASSAY;

EID: 84900422658     PISSN: None     EISSN: 19485875     Source Type: Journal    
DOI: 10.1021/ml400521f     Document Type: Article

References (47)

1. Shimozono, S.; Iimura, T.; Kitaguchi, T.; Higashijima, S.-I.; Miyawaki, A. Visualization of an endogenous retinoic acid gradient across embryonic development Nature 2013, 496, 363-366
2. Mark, M.; Ghyselinck, N.; Chambon, P. Function of retinoid nuclear receptors: lessons from genetic and pharmacological dissections of the retinoic acid signalling pathway during mouse embryogenesis Annu. Rev. Pharmacol. Toxicol. 2006, 46, 451-480
3. Altucci, L.; Leibowitz, M. D.; Ogilvie, K. M.; de Lera, A. R.; Gronemeyer, H. RAR and RXR modulation in cancer and metabolic disease Nat. Rev. Drug Discovery 2007, 6, 793-810
4. Niederreither, K.; Dolle, P. Retinoic acid in development: towards an integrated view Nat. Rev. Genet. 2008, 9, 541-553
5. Germain, P.; Chambon, P.; Eichele, G.; Evans, R. M.; Lazar, M. A.; Leid, M.; de Lera, A. R.; Lotan, R.; Mangelsdorf, D. J.; Gronemeyer, H. The pharmacology and classification of the nuclear receptor superfamily. Retinoic acid receptors (RARs) Pharmacol. Rev. 2006, 58, 712-725
6. Germain, P.; Chambon, P.; Eichele, G.; Evans, R. M.; Lazar, M. A.; Leid, M.; de Lera, A. R.; Lotan, R.; Mangelsdorf, D. J.; Gronemeyer, H. The pharmacology and classification of the nuclear receptor superfamily. Retinoid X receptors (RXRs) Pharmacol. Rev. 2006, 58, 760-772
7. Bourguet, W.; Germain, P.; Gronemeyer, H. Nuclear receptor ligand-binding domains: three-dimensional structures, molecular interactions and pharmacological implications Trends Pharmacol. Sci. 2000, 21, 381-388
8. Altucci, L.; Gronemeyer, H. The promise of retinoids to fight against cancer Nat. Rev. Cancer 2001, 1, 181-193
9. Sun, S. Y.; Lotan, R. Retinoids and their receptors in cancer development and chemoprevention Crit. Rev. Oncol. Hematol. 2002, 41, 41-55
10. Laudet, V.; Gronemeyer, H. The Nuclear Receptor Facts Book; Academic Press: San Diego, CA, 2002.
11. Gronemeyer, H.; Gustafsson, J.-A.; Laudet, V. Principles for modulation of the nuclear receptor superfamily Nat. Rev. Drug Discovery 2004, 3, 950-964
12. Germain, P.; Iyer, J.; Zechel, C.; Gronemeyer, H. Co-regulator recruitment and the mechanism of retinoic acid receptor synergy Nature 2002, 415, 187-192
13. Shulman, A. I.; Larson, C.; Mangelsdorf, D. J.; Ranganathan, R. Structural determinants of allosteric ligand activation in RXR heterodimers Cell 2004, 116, 417-429
14. Petkovich, M.; Brand, N. J.; Kurst, A.; Chambon, P. A human retinoic acid receptor which belongs to the family of nuclear receptors Nature 1987, 330, 444-450
15. Heyman, R. A.; Mangelsdorf, D. J.; Dyck, J. A.; Stein, R. B.; Eichele, G.; Evans, R. M.; Thaller, C. 9- cis -Retinoic acid is a high affinity ligand for the retinoid x receptor Cell 1992, 68, 397-406
16. Levin, A. A.; Sturzenbecker, L. J.; Kazmer, S.; Bosakowski, T.; Huselton, C.; Allenby, G.; Speck, J.; Ratzeisen, C.; Rosenberger, M.; Lovey, A.; Grippo, J. F. 9- cis -Retinoic acid stereoisomer binds and activates the nuclear receptor RXR[alpha] Nature 1992, 355, 359-361
17. Bourguet, W.; de Lera, A. R.; Gronemeyer, H. Inverse Agonists and Antagonists of Retinoid Receptors. In Methods in Enzymology; Conn, P. M., Ed.; Academic Press: New York, 2010; Vol. 485, pp 161-195.
18. de Lera, A. R.; Bourguet, W.; Altucci, L.; Gronemeyer, H. Design of selective nuclear receptor modulators: RAR and RXR as a case study Nat. Rev. Drug. Discovery 2007, 6, 811-820
19. Pérez, E.; Bourguet, W.; Gronemeyer, H.; de Lera, A. R. Modulation of RXR function through ligand design Biochim. Biophys. Acta, Mol. Cell Biol. Lipids 2012, 1821, 57-69
20. Renaud, J.-P.; Rochel, N.; Ruff, M.; Vivat, V.; Chambon, P.; Gronemeyer, H.; Moras, D. Crystal structure of the RARγ ligand-binding domain bound to all- trans -retinoic acid Nature 1995, 378, 681-689
21. Klaholz, B. P.; Renaud, J.-P.; Mitschler, A.; Zusi, C.; Chambon, P.; Gronemeyer, H.; Moras, D. Conformational adaptation of agonists to the human nuclear receptor RARγ Nat. Struct. Biol. 1998, 5, 199-202
22. Germain, P.; Kammerer, S.; Pérez, E.; Peluso-Iltis, C.; Tortolani, D.; Zusi, F. C.; Starrett, J. E.; Lapointe, P.; Daris, J.-P.; Marinier, A.; de Lera, A. R.; Rochel, N.; Gronemeyer, H. Rational design of RAR selective ligands revealed by RARβ crystal structure EMBO Rep. 2004, 5, 877-882
23. Bourguet, W.; Ruff, M.; Chambon, P.; Gronemeyer, H.; Moras, D. Crystal structure of the ligand-binding domain of the human nuclear receptor RXRα Nature 1995, 375, 377-382
24. Bourguet, W.; Vivat, V.; Wurtz, J.-M.; Chambon, P.; Gronemeyer, H.; Moras, D. Crystal structure of a heterodimeric complex of RAR and RXR ligand-binding domains Mol. Cell 2000, 5, 289-298
25. Shankaranarayanan, P.; Rossin, A.; Khanwalkar, H.; Alvarez, S.; Alvarez, R.; Jacobson, A.; Nebbioso, A.; de Lera, A. R.; Altucci, L.; Gronemeyer, H. Growth factor-antagonized rexinoid apoptosis involves permissive PPARγ/RXR heterodimers to activate the intrinsic death pathway by NO Cancer Cell 2009, 16, 220-231
26. Loeliger, P.; Bollag, W.; Mayer, H. Arotinoids: a new class of highly active retinoids Eur. J. Med. Chem. 1980, 15, 9-15
27. Beard, R. L.; Chandraratna, R. A. S.; Colon, D. F.; Gillett, S. J.; Henry, E.; Marler, D. K.; Song, T.; Denys, L.; Garst, M. E.; Arefieg, T.; Klien, E.; Gil, D. W.; Wheeler, D. M.; Kochhar, D. M.; Davies, P. J. A. Synthesis and structure-activity relationships of stilbene retinoid analogs substituted with heteroaromatic carboxylic acids J. Med. Chem. 1995, 38, 2820-2829
28. Chen, J. Y.; Penco, S.; Ostrowski, J.; Balaguer, P.; Pons, M.; Starrett, J. E.; Reczek, P.; Chambon, P.; Gronemeyer, H. RAR-specific agonist/antagonists which dissociate transactivation and AP1 transrepression inhibit anchorage-independent cell proliferation EMBO J. 1995, 14, 1187-1197
29. Kagechika, H.; Kawachi, E.; Hashimoto, Y.; Himi, T.; Shudo, K. Retinobenzoic acids. 1. Structure-activity relationships of aromatic amides with retinoidal activity J. Med. Chem. 1988, 31, 2182-2192
30. Delescluse, C.; Cavey, M. T.; Martin, B.; Bernard, B. A.; Reichert, U.; Maignan, J.; Darmon, M.; Shroot, B. Selective high affinity retinoic acid receptor α or β-γ ligands Mol. Pharmacol. 1991, 40, 556-562
31. álvarez, S.; Khanwalkar, H.; álvarez, R.; Erb, C.; Martínez, C.; Rodríguez-Barrios, F.; Germain, P.; Gronemeyer, H.; de Lera, A. R. C3-halogen and C8′-substituents on stilbene arotinoids modulate retinoic acid receptor subtype function ChemMedChem 2009, 4, 1630-1640
32. Klaholz, B. P.; Mitschler, A.; Belema, M.; Zusi, C.; Moras, D. Enantiomer discrimination illustrated by high-resolution crystal structures of the human nuclear receptor hRARγ Proc. Natl. Acad. Sci. 2000, 97, 6322-6327
33. Barluenga, J.; Rodriguez, M. A.; Campos, P. J. Electrophilic additions of positive iodine to alkynes through an iodonium mechanism J. Org. Chem. 1990, 55, 3104-3106
34. Kotha, S.; Lahiri, K.; Kashinath, D. Recent applications of the Suzuki-Miyaura cross-coupling reaction in organic synthesis Tetrahedron 2002, 58, 9633-9695
35. Hartwig, J. F. Carbon-heteroatom bond formation catalysed by organometallic complexes Nature 2008, 455, 314-322
36. Evano, G.; Blanchard, N.; Toumi, M. Copper-mediated coupling reactions and their applications in natural products and designed biomolecules synthesis Chem. Rev. 2008, 108, 3054-3131
37. Han, S.-Y.; Kim, Y.-A. Recent development of peptide coupling reagents in organic synthesis Tetrahedron 2004, 60, 2447-2467
38. Klapars, A.; Antilla, J. C.; Huang, X.; Buchwald, S. L. A general and efficient copper catalyst for the amidation of aryl halides and the N -arylation of nitrogen heterocycles J. Am. Chem. Soc. 2001, 123, 7727-7729
39. Wolter, M.; Klapars, A.; Buchwald, S. L. Synthesis of N -aryl hydrazides by copper-catalyzed coupling of hydrazides with aryl iodides Org. Lett. 2001, 3, 3803-3805
40. Klapars, A.; Huang, X.; Buchwald, S. L. A general and efficient copper catalyst for the amidation of aryl halides J. Am. Chem. Soc. 2002, 124, 7421-7428
41. Kwong, F. Y.; Klapars, A.; Buchwald, S. L. Copper-catalyzed coupling of alkylamines and aryl iodides: an efficient system even in an air atmosphere Org. Lett. 2002, 4, 581-584
42. Vivat, V.; Zechel, C.; Wurtz, J.-M.; Bourguet, W.; Kagechika, H.; Umemiya, H.; Shudo, K.; Moras, D.; Gronemeyer, H.; Chambon, P. A mutation mimicking ligand-induced conformational change yields a constitutive RXR that senses allosteric effects in heterodimers EMBO J. 1997, 16, 5697-5709
43. Klaholz, B. P.; Mitschler, A.; Moras, D. Structural basis for isotype selectivity of the human retinoic acid nuclear receptor J. Mol. Biol. 2000, 302, 155-170
44. Klaholz, B. P.; Moras, D. C-H···O hydrogen bonds in the nuclear receptor RARγ. A potential tool for drug discovery Structure 2002, 10, 1197-1204
45. Goodford, P. J. A computational procedure for determining energetically favorable binding sites on biologically important macromolecules J. Med. Chem. 1985, 28, 849-857
46. Nettles, K. W.; Bruning, J. B.; Gil, G.; O'Neill, E. E.; Nowak, J.; Guo, Y.; Kim, Y.; DeSombre, E. R.; Dilis, R.; Hanson, R. N.; Joachimiak, A.; Greene, G. L. Structural plasticity in the oestrogen receptor ligand-binding domain EMBO Rep. 2007, 8, 563-568
47. García, J.; Khanwalkar, H.; Pereira, R.; Erb, C.; Voegel, J. J.; Collette, P.; Mauvais, P.; Bourguet, W.; Gronemeyer, H.; de Lera, A. R. Pyrazine arotinoids with inverse agonist activities on the retinoid and rexinoid Receptors ChemBioChem 2009, 10, 1252-1259